Healthcare Stocks To Keep An Eye On | Synergy Pharmaceuticals (SGYP) | MannKind Corporation (MNKD) | CIGNA Corporation (CI) | ZIOPHARM Oncology (ZIOP)

Today has been a bit of a mixed market in the healthcare sector so far. However, as always, there are several potential opportunities showing themselves in the market. With that said, I’ve dug up 4 stocks in healthcare that I think are well worth watching. Here’s what they are, and why you should watch them…

Synergy Pharmaceuticals Stock Is Pulling Back | Get Ready For More Gains

Synergy Pharmaceuticals Inc (NASDAQ: SGYP)

Synergy Pharmaceuticals isn’t having a very strong day in the market today. As a matter of fact, the stock is currently (12:55) trading at $8.35 per share after a loss of 7.94% so far today. Nonetheless, as I mentioned in a post earlier today, I’m not concerned at all about the declines as they are what we expect to see in normal market movement. Last week, SGYP had a great time in the market after the release of data from its most recent study into gastrointestinal issues. Since movement in the market is a series of overreactions, it’s not surprising that investors overreacted; sending the stock higher than it should have gone. So, today we’re seeing a bit of a correction. However, the pull-back is likely to open opportunity for more gains. So, now may be the best time to start looking for entrance points.

MannKind Corporation Stock Is Down…Not Out!

MannKind Corporation (NASDAQ: MNKD)

MannKind Corporation stock has been the talk of biotech for quite some time as investors debate the abilities of the company with regard to Afrezza. However, it’s important to remember that Afrezza is still in the pre-launch phase. Soon however, the Direct-to-Consumer campaign will launch; likely sending sales of the inhaled insulin up. So, keep an eye on the declines and look for support because this one is likely to grow long term; and with the Direct-to-Consumer campaign just weeks away, the growth is probably going to start happening relatively soon.

CIGNA Corporation Stock Climbs On Takeover Offer Rejection

CIGNA Corporation (NYSE: CI)

CIGNA Corporation stock realized nice gains late last week as a takeover offer was announced. Anthem, a rival healthcare company offered more than $47 billion to acquire the company. However, CIGNA Corporation declined the offer; stating that the takeover would not be in the best interest of shareholders. As a result, the company’s stock is on the rise yet again today. Currently (1:03), CI is trading at $164.09 per share after a gain of 5.69%. Considering the reason for the increase in value of the stock, and the historic price movements we’ve seen, I’m expecting more long term gains. So, start watching for pull-backs as they will likely generate great opportunities for gains!

ZIOPHARM Oncology Stock Continues To Gain On High Volume


ZIOPHARM Oncology has had a great time in the market recently; trading on high volume all last week. Today is no different. According to CNN Money, the average volume on the stock over the past 50 days has been 3,986,113 shares trading hands per day. However today so far, 4,542,488 shares have traded hands. Considering the fact that the high volume is starting to become a trend, I’m expecting to see great things from ZIOP stock moving forward.

Do You Know Of Any Others?

Are you tracking any other stocks in healthcare that are presenting great opportunities? If so, let us know in the comments below!

Image Credit

Leave a Comment